Total Payments
$15,719
2024 Payments
$155.58
Companies
18
Transactions
63
Medicare Patients
4,277
Medicare Billing
$1.9M
Payment Breakdown by Category
Consulting$5,500 (35.0%)
Other$5,000 (31.8%)
Travel$2,794 (17.8%)
Food & Beverage$2,426 (15.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,500 | 3 | 35.0% |
| Honoraria | $4,000 | 1 | 25.4% |
| Travel and Lodging | $2,794 | 10 | 17.8% |
| Food and Beverage | $2,426 | 48 | 15.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $10,695 | 24 | $0 (2020) |
| Augmenix, Inc. | $3,802 | 7 | $0 (2018) |
| Myriad Genetic Laboratories, Inc. | $331.39 | 6 | $0 (2024) |
| RaySearch Laboratories AB (publ) | $318.00 | 1 | $0 (2018) |
| VIEWRAY TECHNOLOGIES INC | $159.35 | 2 | $0 (2022) |
| EMD Serono, Inc. | $76.96 | 6 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $69.11 | 1 | $0 (2024) |
| Shire North American Group Inc | $50.43 | 3 | $0 (2017) |
| West Therapeutics Development, LLC | $39.47 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $32.89 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155.58 | 6 | Siemens Medical Solutions USA, Inc. ($69.11) |
| 2023 | $331.78 | 6 | Myriad Genetic Laboratories, Inc. ($291.51) |
| 2022 | $26.46 | 1 | VIEWRAY TECHNOLOGIES INC ($26.46) |
| 2021 | $52.81 | 3 | West Therapeutics Development, LLC ($39.47) |
| 2020 | $50.34 | 4 | E.R. Squibb & Sons, L.L.C. ($19.55) |
| 2019 | $132.89 | 1 | VIEWRAY TECHNOLOGIES INC ($132.89) |
| 2018 | $5,033 | 14 | Novocure Inc. ($4,618) |
| 2017 | $9,937 | 28 | Novocure Inc. ($6,062) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2024 | Siemens Medical Solutions USA, Inc. | Varian Ethos Treatment Planning (Device) | Food and Beverage | In-kind items and services | $69.11 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neuroblate | ||||||
| 03/22/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Myriad Genetic Laboratories, Inc. | — | Food and Beverage | In-kind items and services | $84.84 | General |
| 11/30/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $163.91 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: ONCOLOGY | ||||||
| 03/30/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: Oncology | ||||||
| 08/31/2022 | VIEWRAY TECHNOLOGIES INC | MRIdian LINAC (Device) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Radiotherapy | ||||||
| 06/23/2021 | West Therapeutics Development, LLC | Lazanda (Drug), Subsys | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Opioid Agonist | ||||||
| 06/16/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Oncology | ||||||
| 04/21/2021 | West Therapeutics Development, LLC | Lazanda (Drug), Subsys | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Opioid Agonist | ||||||
| 12/01/2020 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Optune | ||||||
| 12/01/2020 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $1.39 | General |
| Category: Optune | ||||||
| 09/16/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Oncology | ||||||
| 07/13/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: VACCINES | ||||||
| 11/05/2019 | VIEWRAY TECHNOLOGIES INC | MRIdian (Device) | Food and Beverage | In-kind items and services | $132.89 | General |
| Category: Radiotherapy | ||||||
| 12/20/2018 | Novocure Inc. | Oncology (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Optune | ||||||
| 10/22/2018 | RaySearch Laboratories AB (publ) | RayStation (Medical Supply) | Food and Beverage | In-kind items and services | $318.00 | General |
| Category: Radiation Oncology | ||||||
| 10/21/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $141.60 | General |
| Category: Optune | ||||||
| 09/20/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $71.09 | General |
| Category: Optune | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,006 | 2,873 | $840,435 | $206,171 |
| 2022 | 21 | 1,281 | 4,184 | $1.6M | $417,736 |
| 2021 | 20 | 1,099 | 4,190 | $2.0M | $554,156 |
| 2020 | 20 | 891 | 3,954 | $2.9M | $730,446 |
Total Patients
4,277
Total Services
15,201
Medicare Billing
$1.9M
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 109 | 294 | $184,920 | $46,633 | 25.2% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 139 | 1,156 | $172,406 | $42,459 | 24.6% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 53 | 57 | $84,884 | $19,998 | 23.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 55 | 71 | $54,182 | $13,482 | 24.9% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 95 | 244 | $49,337 | $12,221 | 24.8% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 74 | 76 | $42,268 | $10,570 | 25.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 22 | 91 | $46,858 | $9,467 | 20.2% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 80 | 292 | $31,664 | $8,000 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 45 | 45 | $30,650 | $6,692 | 21.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 27 | 37 | $15,577 | $5,890 | 37.8% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 23 | 24 | $18,004 | $4,557 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 60 | $21,629 | $4,411 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 61 | 86 | $21,711 | $4,290 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 30 | $14,487 | $3,477 | 24.0% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 24 | 159 | $10,771 | $2,740 | 25.4% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 31 | 37 | $10,166 | $2,430 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $11,342 | $2,195 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $3,476 | $1,696 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $3,262 | $1,523 | 46.7% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 12 | 14 | $4,933 | $1,427 | 28.9% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 24 | 32 | $3,984 | $1,023 | 25.7% |
| 77470 | Special radiation treatment | Facility | 2023 | 11 | 11 | $3,923 | $989.01 | 25.2% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 14 | 289 | $380,934 | $100,480 | 26.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 110 | 328 | $206,097 | $53,314 | 25.9% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 134 | 1,260 | $187,916 | $48,046 | 25.6% |
About Dr. John Wilkinson, M.D
Dr. John Wilkinson, M.D is a Radiation Oncology healthcare provider based in Lompoc, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568621803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wilkinson, M.D has received a total of $15,719 in payments from pharmaceutical and medical device companies, with $155.58 received in 2024. These payments were reported across 63 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($5,500).
As a Medicare-enrolled provider, Wilkinson has provided services to 4,277 Medicare beneficiaries, totaling 15,201 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology, Radiation Oncology
- Location Lompoc, CA
- Active Since 06/02/2008
- Last Updated 01/09/2020
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1568621803
Products in Payments
- Optune (Device) $6,062
- Oncology (Device) $4,633
- SpaceOAR (Device) $3,802
- RayStation (Medical Supply) $318.00
- PROLARIS (Device) $246.55
- MRIdian (Device) $132.89
- Varian Ethos Treatment Planning (Device) $69.11
- Lazanda (Drug) $39.47
- VYVANSE (Drug) $37.92
- Bavencio (Biological) $37.77
- OPDIVO (Biological) $32.89
- MRIdian LINAC (Device) $26.46
- Axumin (Drug) $26.07
- ALUNBRIG (Drug) $25.49
- XALKORI (Biological) $24.41
- SUBSYS (Drug) $19.68
- Neuroblate (Device) $16.53
- Lenvima (Drug) $16.30
- BEXSERO (Biological) $15.78
- BAVENCIO (Drug) $14.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.